Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis

Background To date there is no evidence that more intensive follow-up after surgery for esophagogastric adenocarcinoma translates into improved survival. This study aimed to evaluate the impact of standardized surveillance by a specialized center after resection on survival. Methods Data of 587 pati...

Full description

Saved in:
Bibliographic Details
Published inGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association Vol. 21; no. 3; pp. 552 - 568
Main Authors Sisic, Leila, Strowitzki, Moritz J., Blank, Susanne, Nienhueser, Henrik, Dorr, Sara, Haag, Georg Martin, Jäger, Dirk, Ott, Katja, Büchler, Markus W., Ulrich, Alexis, Schmidt, Thomas
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.05.2018
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background To date there is no evidence that more intensive follow-up after surgery for esophagogastric adenocarcinoma translates into improved survival. This study aimed to evaluate the impact of standardized surveillance by a specialized center after resection on survival. Methods Data of 587 patients were analyzed who underwent curative surgery for esophagogastric adenocarcinoma in our institution. Based on their postoperative surveillance, patients were assigned to either standardized follow-up (SFU) by the National Center for Tumor Diseases (SFU group) or individual follow-up by other physicians (non-SFU group). Propensity score matching (PSM) was performed to compensate for heterogeneity between groups. Groups were compared regarding clinicopathological findings, recurrence, and impact on survival before and after PSM. Results Of 587 patients, 32.7% were in the SFU and 67.3% in the non-SFU group. Recurrence occurred in 39.4% of patients and 92.6% within the first 3 years; 73.6% were treated, and of those 17.1% underwent resection. In recurrent patients overall and post-recurrence survival (OS/PRS) was influenced by diagnostic tools ( p  < 0.05), treatment ( p  ≤ 0.001), and resection of recurrence ( p  ≤ 0.001). Standardized follow-up significantly improved OS (84.9 vs. 38.4 months, p  = 0.040) in matched analysis and was an independent positive predictor of OS before and after PSM ( p  = 0.034/0.013, respectively). Conclusion After PSM, standardized follow-up by a specialized center significantly improved OS. Cross-sectional imaging and treatment of recurrence were associated with better outcome. Regular follow-up by cross-sectional imaging especially during the first 3 years should be recommended by national guidelines, since early detection might help select patients for treatment of recurrence and even resection in few designated cases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1436-3291
1436-3305
DOI:10.1007/s10120-017-0751-4